Ames FC - Search Results

1

Lower and central tumor location correlates with lymphoscintigraphy drainage to the internal mammary lymph nodes in breast carcinoma.

Shahar KH, Buchholz TA, Delpassand E, Sahin AA, Ross MI, Ames FC, Kuerer HM, Feig BW, Meric-Bernstam F, Babiera GV, Singletary SE, Akins JS, Mirza NQ, Hunt KK. Shahar KH, et al. Among authors: ames fc. Cancer. 2005 Apr 1;103(7):1323-9. doi: 10.1002/cncr.20914. Cancer. 2005. PMID: 15726547 Free article.

2

Breast conservation after neoadjuvant chemotherapy.

Chen AM, Meric-Bernstam F, Hunt KK, Thames HD, Outlaw ED, Strom EA, McNeese MD, Kuerer HM, Ross MI, Singletary SE, Ames FC, Feig BW, Sahin AA, Perkins GH, Babiera G, Hortobagyi GN, Buchholz TA. Chen AM, et al. Among authors: ames fc. Cancer. 2005 Feb 15;103(4):689-95. doi: 10.1002/cncr.20815. Cancer. 2005. PMID: 15641036 Free article.

3

A prospective study comparing touch imprint cytology, frozen section analysis, and rapid cytokeratin immunostain for intraoperative evaluation of axillary sentinel lymph nodes in breast cancer.

Krishnamurthy S, Meric-Bernstam F, Lucci A, Hwang RF, Kuerer HM, Babiera G, Ames FC, Feig BW, Ross MI, Singletary E, Hunt KK, Bedrosian I. Krishnamurthy S, et al. Among authors: ames fc. Cancer. 2009 Apr 1;115(7):1555-62. doi: 10.1002/cncr.24182. Cancer. 2009. PMID: 19195040 Free PMC article.

4

Pathologic tumor response in the breast following neoadjuvant chemotherapy predicts axillary lymph node status.

Kuerer HM, Newman LA, Buzdar AU, Dhingra K, Hunt KK, Buchholz TA, Binkley SM, Strom EA, Ames FC, Ross MI, Feig BW, McNeese MD, Hortobagyi GN, Singletary SE. Kuerer HM, et al. Among authors: ames fc. Cancer J Sci Am. 1998 Jul-Aug;4(4):230-6. Cancer J Sci Am. 1998. PMID: 9689981 Clinical Trial.

5

Role of axillary lymph node dissection after tumor downstaging with induction chemotherapy for locally advanced breast cancer.

Kuerer HM, Newman LA, Fornage BD, Dhingra K, Hunt KK, Buzdar AU, Ames FC, Ross MI, Feig BW, Hortobagyi GN, Singletary SE. Kuerer HM, et al. Among authors: ames fc. Ann Surg Oncol. 1998 Dec;5(8):673-80. doi: 10.1007/BF02303476. Ann Surg Oncol. 1998. PMID: 9869512

6

Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancer.

Kuerer HM, Newman LA, Buzdar AU, Hunt KK, Dhingra K, Buchholz TA, Binkley SM, Ames FC, Feig BW, Ross MI, Hortobagyi GN, Singletary SE. Kuerer HM, et al. Among authors: ames fc. Am J Surg. 1998 Dec;176(6):502-9. doi: 10.1016/s0002-9610(98)00253-0. Am J Surg. 1998. PMID: 9926779 Clinical Trial.

7

Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy.

Kuerer HM, Newman LA, Smith TL, Ames FC, Hunt KK, Dhingra K, Theriault RL, Singh G, Binkley SM, Sneige N, Buchholz TA, Ross MI, McNeese MD, Buzdar AU, Hortobagyi GN, Singletary SE. Kuerer HM, et al. Among authors: ames fc. J Clin Oncol. 1999 Feb;17(2):460-9. doi: 10.1200/JCO.1999.17.2.460. J Clin Oncol. 1999. PMID: 10080586 Clinical Trial.

8

Primary tumor response to induction chemotherapy as a predictor of histological status of axillary nodes in operable breast cancer patients.

Lenert JT, Vlastos G, Mirza NQ, Winchester DJ, Binkley SM, Ames FC, Ross MI, Feig BW, Hunt KK, Strom E, Buzdar AU, Hortobagyi GN, Singletary SE. Lenert JT, et al. Among authors: ames fc. Ann Surg Oncol. 1999 Dec;6(8):762-7. doi: 10.1007/s10434-999-0762-4. Ann Surg Oncol. 1999. PMID: 10622504 Clinical Trial.

9

The feasibility of minimally invasive surgery for stage IIA, IIB, and IIIA breast carcinoma patients after tumor downstaging with induction chemotherapy.

Vlastos G, Mirza NQ, Lenert JT, Hunt KK, Ames FC, Feig BW, Ross MI, Buzdar AU, Singletary SE. Vlastos G, et al. Among authors: ames fc. Cancer. 2000 Mar 15;88(6):1417-24. doi: 10.1002/(sici)1097-0142(20000315)88:6<1417::aid-cncr20>3.0.co;2-1. Cancer. 2000. PMID: 10717625

10

Prognostic implications of pathological lymph node status after preoperative chemotherapy for operable T3N0M0 breast cancer.

Meric F, Mirza NQ, Buzdar AU, Hunt KK, Ames FC, Ross MI, Pollock RE, Newman LA, Feig BW, Strom EA, Buchholz TA, McNeese MD, Hortobagyi GN, Singletary SE. Meric F, et al. Among authors: ames fc. Ann Surg Oncol. 2000 Jul;7(6):435-40. doi: 10.1007/s10434-000-0435-9. Ann Surg Oncol. 2000. PMID: 10894139

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

152 results

Search Page

Filters